Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)

M Roobol; M Kerkhof; F Schröder; J Cuzick; P Sasieni; M Hakama; U Stenman; S Ciatto; V Nelen; M Kwiatkowski; M Lujan; H Lilja; M Zappa; L Denis; F Recker; A Berenguer; M Ruutu; P Kujala; C Bangma; G Aus; T Tammela; A Villers; X Rebillard; S Moss; H de Koning; J Hugosson; A Auvinen

doi:10.1016/j.eururo.2009.07.018

Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)

M Roobol, M Kerkhof, F Schröder, J Cuzick, P Sasieni, M Hakama, U Stenman, S Ciatto, V Nelen, M Kwiatkowski, M Lujan, H Lilja, M Zappa, L Denis, F Recker, A Berenguer, M Ruutu, P Kujala, C Bangma, G AusT Tammela, A Villers, X Rebillard, S Moss, H de Koning, J Hugosson, A Auvinen

Patologian yksikkö

Tutkimustuotos: Artikkeli › Tieteellinen › vertaisarvioitu

191 Sitaatiot (Scopus)

Alkuperäiskieli	Englanti
Sivut	584-591
Julkaisu	Eur Urol
Vuosikerta	56
Numero	4
DOI - pysyväislinkit	https://doi.org/10.1016/j.eururo.2009.07.018
Tila	Julkaistu - 2009
OKM-julkaisutyyppi	A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä

Tutkimusalat

adjusted analysis
contamination
mortality reduction
non compliance
prostate cancer
screening

YK:n kestävän kehityksen tavoitteet

Tämä tuotos edistää seuraavia kestävän kehityksen tavoitteita:

Pääsy asiakirjaan

10.1016/j.eururo.2009.07.018

Siteeraa tätä

Roobol, M., Kerkhof, M., Schröder, F., Cuzick, J., Sasieni, P., Hakama, M., Stenman, U., Ciatto, S., Nelen, V., Kwiatkowski, M., Lujan, M., Lilja, H., Zappa, M., Denis, L., Recker, F., Berenguer, A., Ruutu, M., Kujala, P., Bangma, C., ... Auvinen, A. (2009). Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC). Eur Urol, 56(4), 584-591. https://doi.org/10.1016/j.eururo.2009.07.018

@article{81deaeec6ec84bd0af8b5ad91002e8b3,

title = "Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)",

keywords = "adjusted analysis, contamination, mortality reduction, non compliance, prostate cancer, screening, adjusted analysis, contamination, mortality reduction, non compliance, prostate cancer, screening",

author = "M Roobol and M Kerkhof and F Schr{\"o}der and J Cuzick and P Sasieni and M Hakama and U Stenman and S Ciatto and V Nelen and M Kwiatkowski and M Lujan and H Lilja and M Zappa and L Denis and F Recker and A Berenguer and M Ruutu and P Kujala and C Bangma and G Aus and T Tammela and A Villers and X Rebillard and S Moss and {de Koning}, H and J Hugosson and A Auvinen",

year = "2009",

doi = "10.1016/j.eururo.2009.07.018",

language = "English",

volume = "56",

pages = "584--591",

number = "4",

}

Roobol, M, Kerkhof, M, Schröder, F, Cuzick, J, Sasieni, P, Hakama, M, Stenman, U, Ciatto, S, Nelen, V, Kwiatkowski, M, Lujan, M, Lilja, H, Zappa, M, Denis, L, Recker, F, Berenguer, A, Ruutu, M, Kujala, P, Bangma, C, Aus, G, Tammela, T, Villers, A, Rebillard, X, Moss, S, de Koning, H, Hugosson, J & Auvinen, A 2009, 'Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)', Eur Urol, Vuosikerta 56, Nro 4, Sivut 584-591. https://doi.org/10.1016/j.eururo.2009.07.018

Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC). / Roobol, M; Kerkhof, M; Schröder, F et al.
julkaisussa: Eur Urol, Vuosikerta 56, Nro 4, 2009, s. 584-591.

Tutkimustuotos: Artikkeli › Tieteellinen › vertaisarvioitu

TY - JOUR

T1 - Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)

AU - Roobol, M

AU - Kerkhof, M

AU - Schröder, F

AU - Cuzick, J

AU - Sasieni, P

AU - Hakama, M

AU - Stenman, U

AU - Ciatto, S

AU - Nelen, V

AU - Kwiatkowski, M

AU - Lujan, M

AU - Lilja, H

AU - Zappa, M

AU - Denis, L

AU - Recker, F

AU - Berenguer, A

AU - Ruutu, M

AU - Kujala, P

AU - Bangma, C

AU - Aus, G

AU - Tammela, T

AU - Villers, A

AU - Rebillard, X

AU - Moss, S

AU - de Koning, H

AU - Hugosson, J

AU - Auvinen, A

PY - 2009

Y1 - 2009

KW - adjusted analysis

KW - contamination

KW - mortality reduction

KW - non compliance

KW - prostate cancer

KW - screening

KW - adjusted analysis

KW - contamination

KW - mortality reduction

KW - non compliance

KW - prostate cancer

KW - screening

U2 - 10.1016/j.eururo.2009.07.018

DO - 10.1016/j.eururo.2009.07.018

M3 - Article

SN - 0302-2838

VL - 56

SP - 584

EP - 591

JO - Eur Urol

JF - Eur Urol

IS - 4

ER -